share_log

Apogee Enterprises analyst ratings

Benzinga Analyst Ratings ·  Jun 24, 2022 10:34
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
06/24/2022 3.07% Craig-Hallum $47 → $43 Maintains Hold
04/08/2022 Craig-Hallum Downgrades Buy → Hold
05/13/2020 -54.46% Sidoti & Co. $21 → $19 Maintains Neutral
12/20/2019 -4.12% DA Davidson $35 → $40 Maintains Neutral
06/29/2018 24.64% DA Davidson $47 → $52 Downgrades Buy → Neutral
04/04/2018 Goldman Sachs Downgrades Neutral → Sell

Apogee Enterprises Questions & Answers

What is the target price for Apogee Enterprises (APOG)?

The latest price target for Apogee Enterprises (NASDAQ: APOG) was reported by Craig-Hallum on June 24, 2022. The analyst firm set a price target for $43.00 expecting APOG to rise to within 12 months (a possible 3.07% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Apogee Enterprises (APOG)?

The latest analyst rating for Apogee Enterprises (NASDAQ: APOG) was provided by Craig-Hallum, and Apogee Enterprises maintained their hold rating.

When is the next analyst rating going to be posted or updated for Apogee Enterprises (APOG)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apogee Enterprises, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apogee Enterprises was filed on June 24, 2022 so you should expect the next rating to be made available sometime around June 24, 2023.

Is the Analyst Rating Apogee Enterprises (APOG) correct?

While ratings are subjective and will change, the latest Apogee Enterprises (APOG) rating was a maintained with a price target of $47.00 to $43.00. The current price Apogee Enterprises (APOG) is trading at is $41.72, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment